Company · Healthtech & Bio

The Blue Box

thebluebox.ai ↗ ·Barcelona ·Seed

The Blue Box (legally The Blue Box Biomedical Solutions, S.L.) is a Barcelona-based medtech startup building a pain-free, radiation-free breast cancer screening device that analyses volatile organic compounds in a urine sample using proprietary AI algorithms, sold as a diagnostics-as-a-service model to gynaecology clinics. The company reports ~88% sensitivity in its research to date, has run studies with 7 hospitals and 450+ women, and is using its July 2025 €3M seed round to fund clinical trials across seven European hospitals targeting CE marking by end of 2026. Founder Judit Giró Benet won the international James Dyson Award for the technology, and the company has been covered by BBC News, TechCrunch, The Guardian and Vogue. It also has a US presence in Menlo Park.

Founded
2021
Founders
2
News
6
Rounds
2
Investors
6
SectorsHealthtech & Bio, Medtech, AI & Data, Femtech, Diagnostics, Deeptech Start-up MapHealthtech & Bio › Diagnostics & precision medicine testing

Profile updated 10 Aug 2026

Founders

Judit Giró Benet
Co-founder & CEO
Lidia Navarro Farré
Co-founder & COO

Global models

No comparables on record yet.

Investors 6

Asociación Española Contra el Cáncer (AECC)
Investor Spain
Investor
Grow Venture Partners
growventurepartners.com
Investor Spain
Hans(wo)man Group
Investor Austria
Krups Family Office
Investor United States
Unconventional Ventures
Investor Denmark

Funding rounds 2

Seed · €3M
The Blue Box closed a €3M seed round led by Nordic impact fund Unconventional Ventures to advance its AI-powered, urine-based breast cancer …
2025-07-10
Pre-seed · €500K
Barcelona medtech The Blue Box closed a €500,000 round led by Grow Venture Partners with participation from Unconventional Ventures, to fund…
2024-07-29

News & media 6

Start typing to search across everything.
↑↓ navigate↵ openesc close